RxDoctor Payments Data

Peggie Parks, PA

Physician Assistant · Mount Olive, NCNPI 1265409254

Payments from drug & device makers

$2,910in general payments, 2019–2025

Across 187 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$432
  • Novo Nordisk$283
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$183
  • AstraZeneca$160
  • Amgen$150
  • Lilly USA, LLC$131
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$2,910100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,910 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$100,666
Medicare patients
271
Services billed
3,924

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide154$162,335
JardianceEmpagliflozin153$127,172
FarxigaDapagliflozin Propanediol78$61,082
EliquisApixaban71$59,987
RybelsusSemaglutide58$55,124
MounjaroTirzepatide48$50,832
Synjardy XrEmpagliflozin/Metformin Hcl47$40,516
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$34,277
LinzessLinaclotide50$33,958
XareltoRivaroxaban26$27,424
Repatha SureclickEvolocumab36$25,227
Tresiba Flextouch U-100Insulin Degludec44$19,652
Aimovig AutoinjectorErenumab-Aooe22$16,275
MyrbetriqMirabegron18$15,548
Repatha SyringeEvolocumab18$12,479

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$283$217,459212 claims
Boehringer IngelheimJardiance, Synjardy Xr$82$167,688200 claims
AstraZenecaFarxiga, Symbicort$160$66,510101 claims
PfizerEliquis, Paxlovid$19$62,78483 claims
Lilly USA, LLCMounjaro, Trulicity$131$61,45559 claims
AbbVieLinzess, Synthroid$432$37,22184 claims
GSKTrelegy Ellipta$70$34,27732 claims
Johnson & JohnsonXarelto$13$27,42426 claims
Astellas Pharma US IncMyrbetriq$63$15,54818 claims
MerckJanuvia$54$8,43215 claims
Sumitomo Pharma America, Inc.Gemtesa$41$6,81714 claims
Arbor Pharmaceuticals, Inc.Edarbyclor$12$2,90012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Mount Olive

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →